跳至主要内容
临床试验/JPRN-UMIN000044759
JPRN-UMIN000044759已完成未知

A dose-ranging study to evaluate the effects of plant extract on reducing serum triglyceride levels - A dose-ranging study to evaluate the effects of plant extract on reducing serum triglyceride levels

Soiken Inc.0 个研究点目标入组 72 人开始时间: 2021年7月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Soiken Inc.
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subjects receiving a medical treatment for dyslipidemia 2) Subjects receiving a medical treatment for serious cardio-vascular, hepatic, renal, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 3) Subjects who have the possibility of developing allergic symptoms by the test food 4) Subjects who take Foods for Specified Health Uses or Foods with Function Claims labeled the functions related to lipid metabolism (triglyceride reduction, LDL cholesterol reduction, etc) 5) Subjects who take foods having the effects related to lipid metabolism (triglyceride reduction, LDL cholesterol reduction, etc) 6) Female subjects who are pregnant or lactating, or intending to become pregnant during the study 7) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 8) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 9) Subjects deemed unsuitable by the investigator

研究者

发起方
Soiken Inc.

相似试验

尚未招募
Unknown
A dose-ranging study to evaluate the effects of probiotics-containing foods on improving bowel movement -a randomized double-blind placebo-controlled study
JPRN-UMIN000052253Morishita Jintan Co., Ltd.60
进行中(未招募)
不适用
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmahouse dust mite-associated allergic asthmaMedDRA version: 17.0Level: LLTClassification code 10020419Term: House dust mite allergySystem Organ Class: 100000004870MedDRA version: 17.0Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855
EUCTR2013-000487-28-DESTALLERGENES SA480
进行中(未招募)
1 期
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthma
EUCTR2013-000487-28-DKSTALLERGENES SA480
进行中(未招募)
1 期
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmahouse dust mite-associated allergic asthmaMedDRA version: 14.1Level: LLTClassification code 10020419Term: House dust mite allergySystem Organ Class: 100000004870MedDRA version: 14.1Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855
EUCTR2013-000487-28-SKSTALLERGENES SA480
进行中(未招募)
不适用
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthma
EUCTR2013-000487-28-CZSTALLERGENES SA480